Immatics (IMTX) Net Equity Issued and Repurchased (2020 - 2025)

Immatics (IMTX) reported Net Equity Issued and Repurchased of $124.9 million for Q4 2025, down 30.62% on a YoY basis from $180.0 million in Q4 2024, and up 2670825.82% sequentially from $4676.2 in Q3 2025.

Immatics (IMTX) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Immatics (IMTX) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $124.9 million in Q4 2025.

  • For the quarter ending Q4 2025, Net Equity Issued and Repurchased fell 30.62% year-over-year to $124.9 million; the trailing twelve-month figure through Dec 2025 stood at $305.0 million (down 17.51% YoY), and the FY2025 full-year result was $121.2 million, down 67.34% from the prior year.
  • Net Equity Issued and Repurchased improved to $124.9 million in Q4 2025, from $4676.2 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $201.7 million in Q1 2024 to a low of -$97.2 million in Q4 2023.
  • A 5-year average of $52.1 million and a median of $3.9 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
  • Across the five-year window, Net Equity Issued and Repurchased soared 532544.04% in 2022 and tumbled 183.93% in 2023, its largest moves.
  • Tracing IMTX's Net Equity Issued and Repurchased over 5 years: stood at $21735.4 in 2021, then soared by 532544.04% to $115.8 million in 2022, then plunged by 183.93% to -$97.2 million in 2023, then surged by 285.25% to $180.0 million in 2024, then plunged by 30.62% to $124.9 million in 2025.
  • Business Quant data shows IMTX's Net Equity Issued and Repurchased at $124.9 million in Q4 2025, $4676.2 in Q3 2025, and $180.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Immatics 1.14 Bn 1.14 Bn - 124.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 124.90 Mn
Dec 31, 2025 124.90 Mn
Sep 30, 2025 4,676.22
Sep 30, 2025 4,676.22
Dec 31, 2024 180.01 Mn
Dec 31, 2024 180.01 Mn
Sep 30, 2024 85,661.12
Sep 30, 2024 85,661.12
Jun 30, 2024 -12.05 Mn
Jun 30, 2024 -12.05 Mn
Mar 31, 2024 201.70 Mn
Mar 31, 2024 201.70 Mn
Dec 31, 2023 -97.17 Mn
Dec 31, 2023 -97.17 Mn
Sep 30, 2023 56.38 Mn
Sep 30, 2023 56.38 Mn
Dec 31, 2022 115.77 Mn
Dec 31, 2022 115.77 Mn
Sep 30, 2022 3.93 Mn
Sep 30, 2022 3.93 Mn